Immune signaling by RIG-I-like receptors
By Y. Loo, M. Gale. Immunity, 2011
1,808 citations recorded by the source corpus.
The RIG-I-like receptors (RLRs) RIG-I, MDA5, and LGP2 play a major role in pathogen sensing of RNA virus infection to initiate and modulate antiviral immunity. The RLRs detect viral RNA ligands or processed self RNA in the cytoplasm to triggers innate immunity and inflammation and to impart gene expression that serves to control infection. Importantly, RLRs cooperate in signaling crosstalk networks with Toll-like receptors and other factors to impart innate immunity and to modulate the adaptive immune response. RLR regulation occurs at a variety of levels ranging from autoregulation to ligand and co-factor interactions and post-translational modifications. Abberant RLR signaling or dysregulation of RLR expression is now implicated in the development of autoimmune diseases. Understanding the processes of RLR signaling and response will provide insights to guide RLR-targeted therapeutics for antiviral and immune modifying applications.
Subfields: Immunology, Molecular Biology, Oncology
View Paper: https://www.semanticscholar.org/paper/d0031bd686a72304b2eff3292bca1d46dedd1a17
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Immunology
- Anna Marie Pyle
- Shizuo Akira
- Taro Kawai
- David C. Rawling
- Megan E. Fitzgerald
- Andrew S. Kohlway
- A. West
- Tadatsugu Taniguchi
In Molecular Biology
- Anna Marie Pyle
- David C. Rawling
- Megan E. Fitzgerald
- Andrew S. Kohlway
- Taro Kawai
- Andy J. Minn
- Shizuo Akira
- A. West
In Oncology
- Shizuo Akira
- Taro Kawai
- Anna Marie Pyle
- A. Aschenbrenner
- Tadatsugu Taniguchi
- Joachim L. Schultze
- A. Mócsai
- J. Slingerland
Citations in the corpus
- Exosome transfer from stromal to breast cancer cells regulates therapy resistance pathways. (2014, background): “This expands BrCa subpopulations adept at resisting therapy and reinitiating tumor growth.”
- Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. (2011, background): “TLR7 is reported to recognize RNA from Group B streptococci within the lysosomal compartment (Mancuso et al., 2009).”
- DEAD-Box Helicases: Sensors, Regulators, and Effectors for Antiviral Defense (2020, background): “DDX1 contributes to IFN-β activation during transmissible gastroenteritis virus infection via its interaction with the nonstructural protein nsP14 [18] and interacts with RelA potentiating NF-κB-dependent transcription, a function which requires intact helicase activity [19].”
- COVID-19 and the human innate immune system (2021, background): “…activated kinase (encoded byMAP3 complex of Toll-like receptors 7 and 8, TLR7 also known as CD287 and CD288 receptor-associated factor 3/6; TRIF, TIR-domain-containing adaptor-inducing i 1676 Cell 184, April 1, 2021 scription of type I IFNs and numerous ISGs are induced (Loo and Gale, 2011).”
- Neutrophil cell surface receptors and their intracellular signal transduction pathways (2013, background): “Intracellular viruses are in part recognized by RIG-I-like receptors, a family of RNA helicases that function as cytoplasmic sensors of double-strandedRNA [225].”
- Apoptotic caspases prevent the induction of type I interferons by mitochondrial DNA (2014, background): “the Induction of Type I Interferons by Mitochondrial DNA”